Locations:
SearchOur latest performance data in these areas plus HOCM and pericarditis
Below we share recent volumes and clinical outcomes from a sampling of disciplines and subspecialty areas in Cleveland Clinic’s Heart, Vascular and Thoracic Institute: thoracic surgery, lung transplantation, hypertrophic obstructive cardiomyopathy and pericarditis.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Number of general thoracic operations performed
Number of robotically assisted thoracic surgery procedures
Proportion of lobectomies for stage I lung cancer (N = 233) that used video/robot-assisted thoracoscopic surgery
Proportion of thymectomy/thymic mass resections (N = 32) completed robotically
The following data and ratings are from the Society of Thoracic Surgeons (STS) General Thoracic Surgery Database (3-year period ending December 2024):
Total lung transplants performed, including 3 heart/lung, 5 lung/liver and 1 lung/liver/kidney
Lung transplants performed after ex vivo lung perfusion (EVLP)
30-day survival rate following EVLP lung transplant
Outpatient visits for HOCM
New HOCM patients seen
Septal myectomy procedures (with or without other procedures) performed for HOCM
Observed-to-expected mortality ratio for septal myectomy*
*According to Vizient® Clinical Data Base/Resource Manager. Used by permission of Vizient. All rights reserved.
Patients seen by our Pericardial Diseases Center
New patients seen by the Pericardial Diseases Center
Pericardial procedures performed
Pericardiectomies performed
Cleveland Clinic’s Heart, Vascular and Thoracic Institute has a long tradition of reporting volume and outcomes data across its subspecialty areas. For more information like the data reported above, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.
Advertisement
Advertisement
Our latest volumes and outcomes data in these areas plus HOCM and pericarditis
Catch up with our latest volumes and outcomes data
End-of-treatment VALOR-HCM analyses reassure on use in women, suggest disease-modifying potential
Enhanced visualization and dexterity enable safer, more precise procedures and lead to better patient outcomes
Insights on bringing Cleveland Clinic even closer to becoming the best transplant enterprise in the world
Potentially cost-effective addition to standard GERD management in post-transplant patients
Consensus statement aims to increase use of the perfusion technology and raise transplant volumes
Cardiac imaging substudy is the latest paper originating from the VANISH trial